[
  {
    "ts": "2025-10-22T15:57:00+00:00",
    "headline": "Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering",
    "summary": "New Spherix Global Insights data reveal growing physician demand for therapies that reduce treatment burden and elevate patient experience.EXTON, PA, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Hematologists across the United States are redefining what “success” looks like in hemophilia treatment, according to the latest findings from Market Dynamix™: Hemophilia (US) 2025 and the accompanying Launch Dynamix™ trackers for Qfitlia (Sanofi), Hympavzi (Pfizer), and Alhemo (Novo Nordisk). The new research from",
    "url": "https://finance.yahoo.com/news/hemophilia-specialists-raise-bar-quality-155700360.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "c9a325fc-c454-38ca-a261-50ebdb969eab",
      "content": {
        "id": "c9a325fc-c454-38ca-a261-50ebdb969eab",
        "contentType": "STORY",
        "title": "Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering",
        "description": "",
        "summary": "New Spherix Global Insights data reveal growing physician demand for therapies that reduce treatment burden and elevate patient experience.EXTON, PA, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Hematologists across the United States are redefining what “success” looks like in hemophilia treatment, according to the latest findings from Market Dynamix™: Hemophilia (US) 2025 and the accompanying Launch Dynamix™ trackers for Qfitlia (Sanofi), Hympavzi (Pfizer), and Alhemo (Novo Nordisk). The new research from",
        "pubDate": "2025-10-22T15:57:00Z",
        "displayTime": "2025-10-22T15:57:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/a64068e15f4b9a2a486bfe332bab53b7",
          "originalWidth": 861,
          "originalHeight": 452,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IEFz4yoyaLGBfQSMLyDVyQ--~B/aD00NTI7dz04NjE7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a64068e15f4b9a2a486bfe332bab53b7.cf.webp",
              "width": 861,
              "height": 452,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sgD8ZgfPNHKYB7K89Avm_Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a64068e15f4b9a2a486bfe332bab53b7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hemophilia-specialists-raise-bar-quality-155700360.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hemophilia-specialists-raise-bar-quality-155700360.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SAN.PA"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-22T14:29:00+00:00",
    "headline": "AbbVie Up More Than 30% in 6 Months: How to Play the Stock",
    "summary": "AbbVie's 30% surge in six months is powered by booming sales of Skyrizi and Rinvoq and renewed strength across oncology and neuroscience.",
    "url": "https://finance.yahoo.com/news/abbvie-more-30-6-months-142900784.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "68c7182a-21a2-3837-98f9-e2aa1eddfd76",
      "content": {
        "id": "68c7182a-21a2-3837-98f9-e2aa1eddfd76",
        "contentType": "STORY",
        "title": "AbbVie Up More Than 30% in 6 Months: How to Play the Stock",
        "description": "",
        "summary": "AbbVie's 30% surge in six months is powered by booming sales of Skyrizi and Rinvoq and renewed strength across oncology and neuroscience.",
        "pubDate": "2025-10-22T14:29:00Z",
        "displayTime": "2025-10-22T14:29:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/59a827b8514d5d6d47690daa5eb16f24",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xubTnAbsCPnw2obvb7FmXA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59a827b8514d5d6d47690daa5eb16f24.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lcL5Qr7_.1czomowImosdw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59a827b8514d5d6d47690daa5eb16f24.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-more-30-6-months-142900784.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-more-30-6-months-142900784.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-22T10:30:00+00:00",
    "headline": "Flagship Pioneering Unveils Expedition Medicines to Expand the Boundaries of Small Molecule Medicines with Generative Design",
    "summary": "Flagship Pioneering, a scientific innovation engine for transformative platforms and products, today unveiled Expedition Medicines™, a company pioneering generative covalent chemistry to expand the boundaries of medicine. Following three years of in-house development, Flagship has committed an initial $50 million to support scaling Expedition's platform for generating small molecule medicines to any target and to further develop its discovery programs in oncology, immunology, and other well-defi",
    "url": "https://finance.yahoo.com/news/flagship-pioneering-unveils-expedition-medicines-103000065.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "ff0740b9-3f0e-3c50-bdb8-71d1fad64d14",
      "content": {
        "id": "ff0740b9-3f0e-3c50-bdb8-71d1fad64d14",
        "contentType": "STORY",
        "title": "Flagship Pioneering Unveils Expedition Medicines to Expand the Boundaries of Small Molecule Medicines with Generative Design",
        "description": "",
        "summary": "Flagship Pioneering, a scientific innovation engine for transformative platforms and products, today unveiled Expedition Medicines™, a company pioneering generative covalent chemistry to expand the boundaries of medicine. Following three years of in-house development, Flagship has committed an initial $50 million to support scaling Expedition's platform for generating small molecule medicines to any target and to further develop its discovery programs in oncology, immunology, and other well-defi",
        "pubDate": "2025-10-22T10:30:00Z",
        "displayTime": "2025-10-22T10:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/1a51427c584f846361c98bc2eeb40827",
          "originalWidth": 400,
          "originalHeight": 158,
          "caption": "(PRNewsfoto/Flagship Pioneering)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6rHyG6AtTObFjtqCyV2n.A--~B/aD0xNTg7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/1a51427c584f846361c98bc2eeb40827.cf.webp",
              "width": 400,
              "height": 158,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aTDm9ReMs6gjIoaonWAeoA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/1a51427c584f846361c98bc2eeb40827.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/flagship-pioneering-unveils-expedition-medicines-103000065.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/flagship-pioneering-unveils-expedition-medicines-103000065.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-22T10:27:00+00:00",
    "headline": "Thermo Scientific Revenue Rises, Boosted by Life Sciences Business",
    "summary": "The scientific services company recorded third-quarter sales of $11.12 billion on the back of growth in its life sciences business.",
    "url": "https://www.wsj.com/health/pharma/thermo-scientific-revenue-rises-boosted-by-life-sciences-business-42243b94?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "a48722f6-39ad-3b39-ae51-01f92238f3fe",
      "content": {
        "id": "a48722f6-39ad-3b39-ae51-01f92238f3fe",
        "contentType": "STORY",
        "title": "Thermo Scientific Revenue Rises, Boosted by Life Sciences Business",
        "description": "",
        "summary": "The scientific services company recorded third-quarter sales of $11.12 billion on the back of growth in its life sciences business.",
        "pubDate": "2025-10-22T10:27:00Z",
        "displayTime": "2025-10-22T10:27:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/a48722f6-39ad-3b39-ae51-01f92238f3fe/thermo-scientific-revenue.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/82cb2692476dc835697f1cd6763bb074",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QPavrGC09X8gSqdTkZRsIg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/82cb2692476dc835697f1cd6763bb074.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QFDHn06z9CAYi5yNHjzPRw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/82cb2692476dc835697f1cd6763bb074.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/thermo-scientific-revenue-rises-boosted-by-life-sciences-business-42243b94?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "AZN.L"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]